Boston Scientific announces results for second quarter 2025

Go back to Boston Scientific announces results for second quarter 2025

Boston Scientific (BSX) PT Raised to $120 at BofA Securities

July 23, 2025 12:19 PM EDT

BofA Securities analyst Travis Steed raised the price target on Boston Scientific (NYSE: BSX) to $120.00 (from $115.00) while maintaining a Buy rating.

The analyst comments "The adjusted income statement had a $100m impact in Q2 with the majority of this being inventory... More